Country

Merz Named “Top Aesthetics Company” by Aesthetic Everything® for Second Year in a Row

CEO Bob Rhatigan named “Top Aesthetics CEO”

Key products Xeomin® and Ultherapy® recognized with best-in-class awards

For the second year in a row, Merz has been recognized as the “Top Aesthetics Company” by Aesthetic Everything® and Bob Rhatigan has been named the “Top Aesthetics CEO.” As part of the annual Aesthetic and Cosmetic Medicine Awards, Merz executives and products were also recognized with 14 additional award wins – 16 total wins overall.

“It is an honor for Merz to be recognized for our products, executives and initiatives by Aesthetic Everything,” said Bob Rhatigan, CEO, Merz Americas. “These awards are a true testament to our commitment and dedication to customers and patients as we strive every day to deliver meaningful results that bring about real progress.”

The full list of awards includes:

• “Top Aesthetics Company” – Merz
• “Top Aesthetics CEO” – Bob Rhatigan
• “Top Aesthetics Chief Commercial Officer” – Patrick Urban
• “Top Aesthetics Vice President” – Jeff Castillo
• “Top Aesthetics Marketing Executive” – Roberto Casas
• “Top Minimally Invasive Procedure” – Xeomin®
• “Top Non-Surgical Procedure” – Ultherapy®
• “Top Skincare Device” – Ultherapy®
• “Top Dermal Fillers” – Radiesse® and BELOTERO BALANCE®
• “Top Body Shaping Device” – Cellfina®
• “Top Skin Care Line” – Neocutis®
• “Top Spa Skin Care Line” – Neocutis®
• “Top Scar and Skin Repair Line” – Mederma®
• “Top Training Center” – Merz Institute for Advanced Aesthetics (MIAA)
• “Top Charitable Effort” – Merz Cares

Aesthetic Everything, the largest social network built exclusively for aesthetic professionals, announces award winners annually. More than 30,000 votes were cast in this year’s awards, applauding outstanding achievement in the aesthetic industry in areas of treatment, products, management, leadership and more.

Merz in the Americas
Merz has a direct presence in six countries in the Americas, as well as a network of selected professional distribution partners in South and Central America and the Caribbean. Merz in the Americas is headquartered in Raleigh, North Carolina, and has facilities in Mesa, Arizona, Franksville, Wisconsin, as well as offices in Toronto, Canada, Mexico City, Bogotá, Colombia, São Paolo, Brazil and Buenos Aires, Argentina. For more information, visit www.merzusa.com.

About Ultherapy®
Ultherapy® is the first and only treatment FDA-cleared to non-invasively lift the skin on eyebrow, neck, and chin, as well as to improve lines and wrinkles on the décolletage. Ultherapy® is also the only cosmetic procedure to use ultrasound imaging, which allows physicians to see the layers of tissue targeted during the treatment to ensure the energy is being deposited where it will be most beneficial. The most common side effects reported in clinical trials were redness, swelling, pain and transient nerve effects. Reported adverse events from post-marketing surveillance are available in the Instructions for Use (IFU). Please see the IFU for product and safety information, including a full list of these events at www.Ultherapy.com/IFU.

About Cellfina®
The Cellfina® System is the first long-lasting, minimally invasive cosmetic procedure proven to smooth away cellulite dimples in the buttocks and thighs for at least three years in a single treatment. Safety and effectiveness in other anatomical areas have not been established. The most common side effects reported were soreness, tenderness, and bruising. The Cellfina® System is only available through a licensed physician. For full product and safety information, visit www.Cellfina.com/IFU.

About Neocutis®
Neocutis® is dedicated to being the most admired, trusted and innovative physician-dispensed skincare brand. Neocutis strives to fulfill this mission by developing exclusive technology platforms based on cutting-edge scientific research. Incorporating targeted technologies into luxurious product formulas enables Neocutis® to deliver innovative skincare solutions that address key skincare concerns, including the signs of aging, discoloration, oxidative stress, skin redness and dryness. For more information about Neocutis®, please visit www.neocutis.com.

About Mederma®
The Mederma® line of skin care and scar creams are topical products that may be used on scars on the face and the body resulting from injury, cuts, surgery, burns and acne. The Mederma® family of products for scar care and stretch mark therapy is available at major retail, grocery, and drug stores nationwide, in addition to online retailers. Mederma PM® Intensive Overnight Scar Cream is a topical cream that is only available by prescription. For more information about Mederma®, please visit www.mederma.com.

About RADIESSE® and BELOTERO BALANCE®
RADIESSE and BELOTERO BALANCE are dermal fillers that are FDA-approved to smooth moderate to severe facial wrinkles and folds, such as nasolabial folds (the creases that extend from the corner of your nose to the corner of your mouth).

You should not use RADIESSE or BELOTERO BALANCE if you have a history of severe allergies or anaphylaxis, or if you are pregnant or breastfeeding. You should not use RADIESSE if you have an allergy to any part of the product, or if you have a bleeding disorder. You should not use BELOTERO BALANCE if you have an allergy to gram-positive bacterial proteins.

If RADIESSE or BELOTERO BALANCE is injected into a blood vessel, serious complications can result including stroke, vision abnormalities, blindness, temporary scabs and permanent scars.

The most common adverse events seen in clinical studies with BELOTERO BALANCE were swelling, bruising, redness, hardening of the skin, pain, altered color or itching. Other adverse events that have occurred with BELOTERO BALANCE include headache, swelling of the side of the nose, moderate cold sore, lip numbness, and lip dryness. Side effects were often mild to moderate and usually resolved within 7 days.

The most common adverse events seen in clinical studies of RADIESSE® include bruising, redness, swelling, pain, itching and other local side effects.

These are not all the possible adverse events with RADIESSE or BELOTERO BALANCE. For full RADIESSE or BELOTERO BALANCE safety information, please visit www.Radiesse.com, www.belotero.com, or call MyMerz Solutions at 1-844-469-6379.

RADIESSE and BELOTERO BALANCE are available by prescription only.

About XEOMIN® (incobotulinumtoxinA)
Read the Medication Guide before you start receiving XEOMIN (Zeo-min) and each time XEOMIN is given to you as there may be new information. The risk information provided here is not comprehensive. To learn more:
• Talk to your health care provider or pharmacist
• Visit www.xeominaesthetic.com to obtain the FDA-approved product labeling
• Call 1-866-862-1211

Uses XEOMIN is a prescription medicine that is injected into muscles and used to improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults for a short period of time (temporary).
It is not known if XEOMIN is safe and effective in children under 18 years of age.

Warnings

XEOMIN may cause serious side effects that can be life threatening. Call your doctor or get medical help right away if you have any of these problems anytime (hours to weeks) after treatment with XEOMIN:
• Problems with swallowing, speaking, or breathing can happen within hours to weeks after
an injection of XEOMIN if the muscles that you use to breathe and swallow become weak. Death can happen as a complication if you have severe problems with swallowing or breathing after treatment with XEOMIN.
o People with certain breathing problems may need to use muscles in their neck to help them breathe and may be at greater risk for serious breathing problems with XEOMIN.
o Swallowing problems may last for several months, and during that time you may need a feeding tube to receive food and water. If swallowing problems are severe, food or liquids may go into your lungs. People who already have swallowing or breathing problems before receiving XEOMIN have the highest risk of getting these problems.

• Spread of toxin effects. In some cases, the effect of botulinum toxin may affect areas of the body away from the injection site and cause symptoms of a serious condition called botulism. The symptoms of botulism include: loss of strength and muscle weakness all over the body, double vision, blurred vision and drooping eyelids, hoarseness or change or loss of voice, trouble saying words clearly, loss of bladder control, trouble breathing, trouble swallowing.

These symptoms can happen hours to weeks after you receive an injection of XEOMIN. These problems could make it unsafe for you to drive a car or do other dangerous activities.

Do not use XEOMIN if you are allergic to XEOMIN or any of the ingredients in XEOMIN (see the end of this Guide for a list of ingredients in XEOMIN), had an allergic reaction to any other botulinum toxin products such as rimabotulinumtoxinB (MYOBLOC®), onabotulinumtoxinA (BOTOX®, BOTOX® COSMETIC), or abobotulinumtoxinA (DYSPORT®) or have a skin infection at the planned injection site.

Before receiving XEOMIN, tell your doctor about all of your medical conditions, including if you:
• have a disease that affects your muscles and nerves (such as amyotrophic lateral sclerosis [ALS
or Lou Gehrig’s disease], myasthenia gravis or Lambert-Eaton syndrome)
• have had any side effect from any other botulinum toxin in the past
• have a breathing problem such as asthma or emphysema
• have a history of swallowing problems or inhaling food or fluid into your lungs (aspiration)
• have bleeding problems
• have drooping eyelids
• have plans to have surgery
• have had surgery on your face
• are pregnant or plan to become pregnant. It is not known if XEOMIN can harm your unborn baby.
• are breastfeeding or plan to breastfeed. It is not known if XEOMIN passes into breast milk.

Tell your doctor about all of the medicines you take, including prescription and over-the-counter
medicines, vitamins and herbal supplements. Talk to your doctor before you take any new medicines
after you receive XEOMIN.

Using XEOMIN with certain other medicines may cause serious side effects Do not start any new medicines until you have told your doctor that you have received XEOMIN in the past.
Especially tell your doctor if you
• have received any other botulinum toxin product in the last four months
• have received injections of botulinum toxin such as rimabotulinumtoxinB (MYOBLOC®), onabotulinumtoxinA (BOTOX®, BOTOX® COSMETIC) and abobotulinumtoxinA (DYSPORT®) in the past. Be sure your doctor knows exactly which product you received. The dose of XEOMIN
may be different from other botulinum toxin products that you have received.
• have recently received an antibiotic by injection
• take muscle relaxants
• take an allergy or cold medicine
• take a sleep medicine

Ask your doctor if you are not sure if your medicine is one that is listed above.

Know the medicines you take. Keep a list of your medicines with you to show your doctor and pharmacist each time you get a new medicine.

Possible Side Effects

XEOMIN can cause serious side effects that can be life threatening including allergic reactions. Symptoms of an allergic reaction to XEOMIN may include: itching, rash, redness, swelling, wheezing, asthma symptoms, or dizziness or feeling faint. Tell your doctor or get medical help right away if you get wheezing or asthma symptoms, or if you get dizzy or faint. See “Warnings.”

The most common side effect of XEOMIN in people with glabellar lines include:
• headache
These are not all the possible side effects of XEOMIN. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

General information about the safe and effective use of XEOMIN
Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. You can ask your pharmacist or doctor for information about XEOMIN that is written for health professionals.

Active Ingredient: botulinum toxin type A
Inactive Ingredients: human albumin and sucrose

Copyright © 2018 Merz North America, Inc. All rights reserved.

All product names and trademarks are property of their respective owners.

Contact:
Emily Browder
Head of Communications
Merz North America
Emily.Browder@merz.com
Office: (919) 582-8114

Press Contact

Merz North America

Emily Browder
Corporate Communications

 

Phone: +1 919.582.8114